<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Genmab A/S

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Genmab A/S

    Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. Founded in 1999, the company has two approved antibodies, a broad clinical and pre-clinical product pipeline and three proprietary next generation antibody technologies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $1,100,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Jan G. J. van de Winkel, Ph.D.
    • FOUNDED
      1999
    • EMPLOYEES
      251-500
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    MyoKardia, Inc.

    MyoKardia, Inc.

    MyoKardia is a clinical-stage biopharmaceutical company pioneering a precision med...

    MyoKardia is a clinical-stage biopharmaceutical...

    Filing Type:    PU
    Hepion Pharmaceuticals, Inc.

    Hepion Pharmaceuticals, Inc.

    Hepion Pharmaceuticals (Nasdaq: HEPA) is a clinical stage biopharmaceutical compan...

    Hepion Pharmaceuticals (Nasdaq: HEPA) is a clin...

    Filing Type:    PU
    Avalon GloboCare Corp.

    Avalon GloboCare Corp.

    Avalon GloboCare Corp. (NASDAQ: AVCO) is a global intelligent biotech developer an...

    Avalon GloboCare Corp. (NASDAQ: AVCO) is a glob...

    Filing Type:    PU
    SeaSpine Holdings Corporation

    SeaSpine Holdings Corporation

    We are a global medical technology company focused on the design, development and ...

    We are a global medical technology company focu...

    Filing Type:    PU
    Repligen Corporation

    Repligen Corporation

    Repligen Corporation is a global bioprocessing company that develops and commercia...

    Repligen Corporation is a global bioprocessing ...

    Filing Type:    PU
    CRISPR Therapeutics AG

    CRISPR Therapeutics AG

    We are rapidly translating our specific, efficient and versatile CRISPR/Cas9 gene-...

    We are rapidly translating our specific, effici...

    Filing Type:    PU
    IGM Biosciences, Inc.

    IGM Biosciences, Inc.

    Headquartered in Mountain View, California, IGM Biosciences is a biotechnology com...

    Headquartered in Mountain View, California, IGM...

    Filing Type:    PU
    Immunomedics, Inc.

    Immunomedics, Inc.

    Immunomedics is a clinical-stage biopharmaceutical company developing monoclonal a...

    Immunomedics is a clinical-stage biopharmaceuti...

    Filing Type:    PU
    Personalis, Inc.

    Personalis, Inc.

    Personalis, Inc. is a growing cancer genomics company transforming the development...

    Personalis, Inc. is a growing cancer genomics c...

    Filing Type:    PU
    Agenus Inc.

    Agenus Inc.

    Agenus is an immuno-oncology company designed to deliver innovation with speed for...

    Agenus is an immuno-oncology company designed t...

    Filing Type:    PU
    Synthorx, Inc.

    Synthorx, Inc.

    Synthorx is a biotechnology company focused on prolonging and improving the lives ...

    Synthorx is a biotechnology company focused on ...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.